Akoya Biosciences Inc. (AKYA)
NASDAQ: AKYA
· Real-Time Price · USD
1.29
-0.07 (-5.15%)
At close: Jul 07, 2025, 3:59 PM
Akoya Biosciences Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -15.65M | -8.2M | -10.53M | -13.15M | -23.48M | -10.8M | -12.92M | -20.8M | -18.8M | -18.88M | -17.87M | -17.5M | -16.4M | -17.67M | -11.62M | -5.56M | -8.08M |
Depreciation & Amortization | 1.8M | 1.85M | 1.82M | 1.93M | 2.05M | 2.11M | 2.58M | 2.09M | 2.12M | 1.9M | 1.94M | 1.69M | 1.62M | 1.37M | 1.24M | 1.13M | 1.04M |
Stock-Based Compensation | 2.25M | 2.15M | 1.88M | 2.71M | 2.57M | 2.56M | 2.88M | 2.62M | 2.38M | 2.12M | 2.04M | 1.72M | 1.54M | 1.41M | 1.16M | 1.22M | 254K |
Other Working Capital | n/a | 980K | 10.04M | 3.08M | -3.02M | -148K | -1.7M | 1.01M | -556K | 4.24M | 4.49M | 836K | -2.94M | 4.85M | -2.48M | -3.53M | -161K |
Other Non-Cash Items | n/a | 784K | -14.47M | 1.26M | 18.08M | 1.08M | 3.67M | 1.87M | 400K | 663K | 477K | -1.08M | 305K | 1.13M | 331K | -1.11M | 2.4M |
Deferred Income Tax | 11K | -71K | 38K | n/a | 37K | -51K | -2.2M | 2.19M | n/a | -64K | n/a | 89K | 10K | -119K | -20K | -6K | -10K |
Change in Working Capital | n/a | 506K | 12M | -3.79M | -8.21M | -452K | -7.76M | 227K | -5.85M | 4.25M | 1.24M | 1.69M | -5.01M | 8.02M | -4.49M | -8.08M | -9K |
Operating Cash Flow | -7.21M | -2.98M | -9.26M | -11.04M | -20.82M | -5.55M | -13.75M | -11.8M | -19.76M | -10.01M | -12.17M | -13.39M | -17.93M | -5.85M | -13.39M | -12.41M | -4.4M |
Capital Expenditures | -204K | -1.04M | -434K | -170K | -810K | -594K | -832K | -1.42M | -804K | -869K | -3.79M | -1.56M | -1.14M | -1.36M | -1.88M | -947K | -907K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 55K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -3.75M | -16.96M | -17.55M | -21.78M | -48.01M | n/a | n/a | n/a | n/a | -23.05M | n/a | -40.77M | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | 20M | 20.7M | 31M | 31M | n/a | n/a | n/a | n/a | 7M | 23M | 11.05M | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | -48.01M | n/a | n/a | n/a | 7M | 23M | 11.05M | -40.77M | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | 16.04M | 2.69M | 13.02M | 9.05M | -48.82M | -594K | -832K | -1.42M | 6.2M | 22.13M | 7.27M | -42.34M | -1.14M | -1.36M | -1.88M | -947K | -907K |
Debt Repayment | n/a | -502K | -166K | -173K | -181K | 11.07M | -175K | -173K | -148K | 11.09M | 9.86M | 9.81M | -126K | -72K | -74K | -128K | -48K |
Common Stock Repurchased | n/a | n/a | 214K | -65K | -149K | 94K | n/a | n/a | -94K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -1.44M | n/a | n/a | -1.19M |
Other Financial Acitivies | -70K | 16K | 16K | -1.95M | -263K | n/a | 34K | 46.5M | -271K | -817K | 2K | -1.14M | 55K | 221K | 30K | 137.06M | 44K |
Financial Cash Flow | -250K | -486K | -150K | -2.13M | -444K | 11.04M | -141K | 46.33M | -419K | 10.27M | 9.86M | 8.67M | -71K | 149K | -44K | 136.93M | -4K |
Net Cash Flow | 8.58M | -775K | 3.61M | -4.11M | -70.09M | 4.53M | -14.73M | 33.1M | -13.98M | 22.39M | 4.96M | -47.06M | -19.14M | -7.07M | -15.31M | 123.57M | -5.32M |
Free Cash Flow | -7.42M | -4.02M | -9.69M | -11.21M | -21.63M | -6.14M | -14.59M | -13.23M | -20.56M | -10.88M | -15.96M | -14.95M | -19.07M | -7.22M | -15.27M | -13.36M | -5.31M |